July - September 2023, Volume 19, Issue 3

Gafencu M, Steflea RM

Actualities in the Management of Secondary Hyperparathyroidism Due to Chronic Kidney Disease in Children

Acta Endo (Buc) 2023, 19 (3): 403-406
doi: 10.4183/aeb.2023.403

Pediatric chronic kidney disease (CKD) has a substantial global impact because is associated with notable morbidity. Secondary hyperparathyroidism (SPHT) frequently emerges as a complication in the early stages of renal insufficiency, it is an adaptive response to uphold mineral balance. It is a component of the chronic kidney disease-mineral and bone disorder (CKD-MBD). The development of SHPT in CKD involves multiple factors and it is important to understand them in order to properly manage it, starting with early diagnosis and continuing with proper treatment. In children with CKD and SHPT, the difficulty in case management is due to non-adherence to proper diet which makes it difficult for the pediatric nephrologist to manage the case. In this review we want to focus on new data regarding this CKD complication.

Keywords: Children CKD, secondary hyperparathyroidism.

Correspondence: Mihai Gafencu MD, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Nephrology, 2nd E. Murgu Square, Timisoara, 300041, Romania, E-mail: mgafencu@umft.ro